Zoledronic acid sensitizes rhabdomyosarcoma cells to cytolysis mediated by human γδ T cells.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Oncology Letters

• Publication date

  2017-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/ol.2017.6894PMID 29113188PMCID PMC5656036
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vγ9Vδ2 T cells and zoledronate mediate antitumor activity in an orthotopic mouse model of human chondrosarcoma

  2016cited by this paper
• Trastuzumab enhanced the cytotoxicity of Vγ9Vδ2 T cells against zoledronate-sensitized osteosarcoma cells.

  2015cited by this paper
• Cancer-targeted IL-12 controls human rhabdomyosarcoma by senescence induction and myogenic differentiation

  2015cited by this paper
• Adoptive immunotherapy against sarcomas

  2015cited by this paper
• Mechanisms of the antitumor activity of human Vγ9Vδ2 T cells in combination with zoledronic acid in a preclinical model of neuroblastoma.

  2013cited by this paper
• Targeting gamma delta T cells for cancer immunotherapy: bench to bedside

  2013cited by this paper
• Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft‐tissue Sarcoma committee experience and rationale for current COG studies

  2012cited by this paper
• Adoptive Immunotherapy for Advanced Non-small Cell Lung Cancer Using Zoledronate-expanded &ggr;&dgr; T Cells: A Phase I Clinical Study

  2011cited by this paper
• Bisphosphonates in preclinical bone oncology.

  2011cited by this paper
• γδ T-cell killing of primary follicular lymphoma cells is dramatically potentiated by GA101, a type II glycoengineered anti-CD20 monoclonal antibody

  2011cited by this paper
• Bisphosphonates: the first 40 years.

  2011cited by this paper
• Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation

  2010cited by this paper
• gammadelta T cells in cancer immunotherapy: current status and future prospects.

  2009cited by this paper
• Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European cooperative groups.

  2008cited by this paper
• Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.

  2007cited by this paper
• Lysis of a Broad Range of Epithelial Tumour Cells by Human γδ T Cells: Involvement of NKG2D ligands and T‐cell Receptor‐ versus NKG2D‐dependent Recognition

  2007cited by this paper
• Bisphosphonates in cancer therapy.

  2007cited by this paper
• Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.

  2007cited by this paper
• Activation of V gamma 9V delta 2 T cells by NKG2D.

  2005cited by this paper
• Human T Cell Receptor γδ Cells Recognize Endogenous Mevalonate Metabolites in Tumor Cells

  2003cited by this paper
• Human gammadelta T cells: a nonredundant system in the immune-surveillance against cancer.

  2002cited by this paper
• Bisphosphonates in cancer therapy

  2002cited by this paper
• Targeting of tumor cells for human gammadelta T cells by nonpeptide antigens.

  2001cited by this paper
• [gamma][delta] cells: a right time and a right place for a conserved third way of protection.

  2000cited by this paper
• Gamma/delta T-cell stimulation by pamidronate.

  1999cited by this paper
• Oncology

  1990cited by this paper

• Uncovering the mysteries of human gamma delta T cells: from origins to novel therapeutics

  2025cites this paper
• Function of γδ T cells in tumor immunology and their application to cancer therapy

  2021cites this paper
• Ectopic parathyroid hormone as a rare aetiology of hypercalcemia with rhabdomyosarcoma: a new treatment strategy with zoledronic acid and Denosumab

  2021cites this paper
• Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL–NKG2D Axis

  2018cites this paper